Effect of Nucleic Acid Amplification Testing on Population-Based Incidence Rates of Clostridium difficile Infection

Thumbnail Image

Files

cit492.pdf (144.15 KB)

Links to Files

https://academic.oup.com/cid/article/57/9/1304/487822

Permanent Link

https://doi.org/10.1093/cid/cit492
 http://hdl.handle.net/11603/29080

Collections

UMBC Emergency and Distaster Health Systems
A. All Hilltop Institute (UMBC) Works
UMBC School of Public Policy

Author/Creator

Author/Creator ORCID

Date

2013-07-29

Type of Work

journal articles
Text

Department

Program

Citation of Original Publication

Carolyn V. Gould and others, Effect of Nucleic Acid Amplification Testing on Population-Based Incidence Rates of Clostridium difficile Infection, Clinical Infectious Diseases, Volume 57, Issue 9, 1 November 2013, Pages 1304–1307, https://doi.org/10.1093/cid/cit492

Rights

This work was written as part of one of the author's official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 U.S.C. 105, no copyright protection is available for such works under U.S. Law.
Public Domain Mark 1.0

Subjects

Abstract

Nucleic acid amplification testing (NAAT) is increasingly being adopted for diagnosis of Clostridium difficile infection (CDI). Data from 3 states conducting population-based CDI surveillance showed increases ranging from 43% to 67% in CDI incidence attributable to changing from toxin enzyme immunoassays to NAAT. CDI surveillance requires adjustment for testing methods.